Published in

Nature Research, Nature Biomedical Engineering, 5(2), p. 279-292, 2018

DOI: 10.1038/s41551-018-0221-2

Links

Tools

Export citation

Search in Google Scholar

Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates

Journal article published in 2018 by Marnix Lameijer, Tina Binderup, Mandy M. T. van Leent, Max L. Senders ORCID, Francois Fay, Joost Malkus, Brenda L. Sanchez-Gaytan, Abraham J. P. Teunissen, Nicolas Karakatsanis ORCID, Philip Robson, Xianxiao Zhou, Yuxiang Ye, Gregory Wojtkiewicz ORCID, Jun Tang ORCID, Tom T. P. Seijkens and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO